imiquimod has been researched along with Body Weight in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agócs, R; Dobosy, P; Kemény, L; Németh, I; Pajtók, C; Pap, D; Szabó, AJ; Szebeni, B; Tulassay, T; Vannay, Á; Veréb, Z; Veres-Székely, A | 1 |
| Hu, Y; Liu, H; Tang, CC; Xiang, TN; Ye, XL; Zheng, YJ | 1 |
| Bhavana, V; Chary, PS; Mehra, NK; Pardhi, E; Singh, SB; Sulthana, S | 1 |
| Alavala, S; Jerald, MK; Nalban, N; Sangaraju, R; Sistla, R | 1 |
| Cho, S; Jin, SP; Kim, MW; Koh, SJ; Lee, DH; Park, HS; Yoon, HS; Yu, DA; Yun, HT | 1 |
| Fukushige, T; Hashiguchi, T; Higashi, Y; Ibusuki, A; Kanekura, T; Yamakuchi, M | 1 |
| Fang, F; Liu, X; Mei, L; Wang, H; Zhang, S | 1 |
| Castleman, WL; Kaplan, MR; Lemanske, RF; Miller, RL; Sorkness, RL; Stokes, JR; Tomai, MA | 1 |
8 other study(ies) available for imiquimod and Body Weight
| Article | Year |
|---|---|
High salt diet impairs dermal tissue remodeling in a mouse model of IMQ induced dermatitis.
Topics: Animals; Biomarkers; Body Weight; Cell Movement; Cells, Cultured; Cytokines; Dermatitis; Dermis; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Humans; Imiquimod; Inflammation; Inflammation Mediators; Leukocytes, Mononuclear; Male; Mice, Inbred C57BL; Probiotics; Sodium Chloride, Dietary | 2021 |
[Reduning Injection protects flu-infected mice by inhibiting infiltration of inflammatory cells in lung and down-regulating cytokine storm].
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Chemokine CCL5; Chemokine CXCL10; Cytokine Release Syndrome; Cytokines; Drugs, Chinese Herbal; Female; Imiquimod; Interleukin-10; Interleukin-6; Lung; Mice; Mice, Inbred C57BL; Oseltamivir; Phosphates; RNA; RNA, Messenger; Tumor Necrosis Factor-alpha; Weight Loss | 2022 |
Development and evaluation emulgel for effective management of the imiquimod-induced psoriasis.
Topics: Animals; Body Weight; Disease Models, Animal; Imiquimod; Inflammation; Male; Mice; Mice, Inbred BALB C; Psoriasis; Skin | 2023 |
Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Cytokines; Dermatitis; Disease Models, Animal; Down-Regulation; Flavonoids; Heme Oxygenase-1; Imiquimod; Male; Membrane Proteins; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Peroxidase; Psoriasis; Signal Transduction; Spleen | 2021 |
Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
Topics: Adjuvants, Immunologic; Animals; Body Weight; Cytokines; Dermatitis; Disease Models, Animal; Epidermis; Imiquimod; Inflammation; Interleukin-10; Interleukin-17; Keratinocytes; Leukocyte Common Antigens; Male; Mice; Mice, Inbred C57BL; Organ Size; Psoriasis; RNA, Messenger; Skin; Spleen; Time Factors | 2018 |
High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice.
Topics: Animals; Body Weight; Cholesterol; Cytokines; Dermatitis; Diet, High-Fat; Disease Models, Animal; Disease Progression; Hyperlipidemias; Imiquimod; Inflammasomes; Inflammation; Male; Mice; Mice, Inbred C57BL; Neutrophils; Psoriasis; Skin | 2018 |
Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice.
Topics: Aminoquinolines; Animals; Antioxidants; Body Weight; Catechin; Cytokines; Imiquimod; Inflammation; Mice; Mice, Inbred BALB C; Psoriasis; Skin; Spleen | 2016 |
Attenuation of virus-induced airway dysfunction in rats treated with imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Body Weight; Bronchoalveolar Lavage Fluid; Imiquimod; Inflammation; Interferons; Male; Rats; Respiratory Tract Diseases; Respirovirus; Respirovirus Infections | 1998 |